Healthcare provider profile · identity verified

Steven J Staehling, M.D.

Family Practice · MEQUON, WI · NPI 1336105501

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	448	113
Amlodipine Besylate	Amlodipine Besylate	333	86
Lisinopril	Lisinopril	277	75
Levothyroxine Sodium	Levothyroxine Sodium	204	46
Losartan Potassium	Losartan Potassium	186	53
Furosemide	Furosemide	180	51
Hydrochlorothiazide	Hydrochlorothiazide	163	48
Pantoprazole Sodium	Pantoprazole Sodium	162	40
Metformin Hcl	Metformin Hcl	145	41
Metoprolol Succinate	Metoprolol Succinate	145	39
Tamsulosin Hcl	Tamsulosin Hcl	142	38
Omeprazole	Omeprazole	137	44
Metformin Hcl Er	Metformin Hcl	133	37
Allopurinol	Allopurinol	126	34
Jardiance	Empagliflozin	114	24
Warfarin Sodium	Warfarin Sodium	100	21
Rosuvastatin Calcium	Rosuvastatin Calcium	90	24
Simvastatin	Simvastatin	87	27
Metoprolol Tartrate	Metoprolol Tartrate	85	22
Gabapentin	Gabapentin	83	22
Tramadol Hcl	Tramadol Hcl	78	18
Carvedilol	Carvedilol	74	21
Lovastatin	Lovastatin	74	17
Albuterol Sulfate Hfa	Albuterol Sulfate	73	27
Mounjaro	Tirzepatide	70	suppressed
Glimepiride	Glimepiride	68	24
Oxycodone Hcl	Oxycodone Hcl	66	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	65	12
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	63	suppressed
Fluticasone Propionate	Fluticasone Propionate	63	24
Glipizide	Glipizide	61	15
Eliquis	Apixaban	58	18
Escitalopram Oxalate	Escitalopram Oxalate	57	18
Zolpidem Tartrate	Zolpidem Tartrate	57	11
Sertraline Hcl	Sertraline Hcl	56	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	11
Potassium Chloride	Potassium Chloride	54	16
Ozempic	Semaglutide	53	suppressed
Pravastatin Sodium	Pravastatin Sodium	50	12
Pioglitazone Hcl	Pioglitazone Hcl	48	suppressed
Meloxicam	Meloxicam	47	30
Finasteride	Finasteride	46	14
Pregabalin	Pregabalin	45	13
Lorazepam	Lorazepam	44	12
Bupropion Xl	Bupropion Hcl	41	12
Solifenacin Succinate	Solifenacin Succinate	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Clonazepam	Clonazepam	37	suppressed
Famotidine	Famotidine	37	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	22
Ezetimibe	Ezetimibe	32	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Atenolol	Atenolol	29	suppressed
Febuxostat	Febuxostat	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	11
Amoxicillin	Amoxicillin	28	17
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Prednisone	Prednisone	22	17
Trulicity	Dulaglutide	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Azelastine Hcl	Azelastine Hcl	21	14
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Nystatin	Nystatin	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Azithromycin	Azithromycin	18	18
Chlorthalidone	Chlorthalidone	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Primidone	Primidone	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Lidocaine	Lidocaine	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Ramipril	Ramipril	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Belsomra	Suvorexant	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Estradiol	Estradiol	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error